Hims & Hers and the end of GLP-1 compounding It was inevitable The New Yorker dubbed 2023 as the year of Ozempic. It wasnt the year that the drug was invented or first given to patients, but it was the year that it exploded into the public consciousness
[1] [2] Sermorelin similarly lacks a current UK marketing authorisation for any adult indication and is not listed in the BNF as a licensed medicine
P., & SURMOUNT-5 Trial Investigators (2025)
H.LapatoA
GLP-1 Weight Loss Medications: The Good, the Bad, and the Ugly And What Theyre Really Doing to Your Muscle, Metabolism, and Long-Term Results December 19, 2025 GLP-1 Weight Loss Medications: The Good, the Bad, and the Ugly And What Theyre Really Doing to Your Muscle, Metabolism, and Long-Term Results Photo Credit: Shutterstock GLP-1 weight loss medications such as Ozempic, Wegovy, Mounjaro, and Zepbound have exploded in popularity over the last few years
Policy Endocrinologist Anira Iqbal, MD, explains why GLP-1s work best the longer you take them